168 related articles for article (PubMed ID: 33367652)
1. Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease.
Kula AJ; Katz R; Zelnick LR; Soliman E; Go A; Shlipak M; Deo R; Ky B; DeBoer I; Anderson A; Christenson R; Seliger SL; Defilippi C; Feldman HI; Wolf M; Kusek J; Shafi T; He J; Bansal N
Nephrol Dial Transplant; 2021 Dec; 36(12):2282-2289. PubMed ID: 33367652
[TBL] [Abstract][Full Text] [Related]
2. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure.
Tummalapalli SL; Zelnick LR; Andersen AH; Christenson RH; deFilippi CR; Deo R; Go AS; He J; Ky B; Lash JP; Seliger SL; Soliman EZ; Shlipak MG; Bansal N;
J Am Heart Assoc; 2020 Jul; 9(13):e014385. PubMed ID: 32578483
[TBL] [Abstract][Full Text] [Related]
3. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Zelnick LR; Soliman EZ; Anderson A; Christenson R; DeFilippi C; Deo R; Feldman HI; He J; Ky B; Kusek J; Lash J; Seliger S; Shafi T; Wolf M; Go AS; Shlipak MG;
Am J Kidney Dis; 2021 Jun; 77(6):907-919. PubMed ID: 33309861
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Bansal N; Zelnick L; Go A; Anderson A; Christenson R; Deo R; Defilippi C; Lash J; He J; Ky B; Seliger S; Soliman E; Shlipak M; ;
J Am Heart Assoc; 2019 Nov; 8(21):e012336. PubMed ID: 31645163
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Biomarkers and Risk of Atherosclerotic Cardiovascular Disease in Patients with CKD.
Lidgard B; Zelnickv L; Anderson AH; Feldman H; Go A; He J; Kansal M; Mohanty MJ; Mehta R; Shlipak MG; Soliman E; Weir MR; Bansal N;
Kidney360; 2022 May; 3(5):859-871. PubMed ID: 36128494
[TBL] [Abstract][Full Text] [Related]
6. Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD.
Bansal N; Zelnick LR; Ballantyne CM; Chaves PHM; Christenson RH; Coresh J; deFilippi CR; de Lemos JA; Daniels LB; Go AS; He J; Hedayati SS; Matsushita K; Nambi V; Shlipak MG; Taliercio JJ; Seliger SL;
Am J Kidney Dis; 2022 Mar; 79(3):383-392. PubMed ID: 34293394
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Hyre Anderson A; Yang W; Christenson RH; deFilippi CR; Deo R; Dries DL; Go AS; He J; Kusek JW; Lash JP; Raj D; Rosas S; Wolf M; Zhang X; Shlipak MG; Feldman HI
J Am Soc Nephrol; 2015 Apr; 26(4):946-56. PubMed ID: 25278510
[TBL] [Abstract][Full Text] [Related]
8. Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.
Bansal N; Zelnick L; Shlipak MG; Anderson A; Christenson R; Deo R; deFilippi C; Feldman H; Lash J; He J; Kusek J; Ky B; Seliger S; Soliman EZ; Go AS;
Clin Chem; 2019 Nov; 65(11):1448-1457. PubMed ID: 31578216
[TBL] [Abstract][Full Text] [Related]
9. Associations Between Cardiac Biomarkers and Cardiac Structure and Function in CKD.
Stein NR; Zelnick LR; Anderson AH; Christenson RH; deFilippi CR; Deo R; Go AS; He J; Ky B; Lash JP; Seliger SL; Soliman EZ; Shlipak MG; Bansal N;
Kidney Int Rep; 2020 Jul; 5(7):1052-1060. PubMed ID: 32647762
[TBL] [Abstract][Full Text] [Related]
10. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure.
Gaggin HK; Szymonifka J; Bhardwaj A; Belcher A; De Berardinis B; Motiwala S; Wang TJ; Januzzi JL
JACC Heart Fail; 2014 Feb; 2(1):65-72. PubMed ID: 24622120
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Biomarkers and Risk of Mortality in CKD (the CRIC Study).
Wang K; Zelnick LR; Anderson A; Cohen J; Dobre M; Deo R; Feldman H; Go A; Hsu J; Jaar B; Kansal M; Shlipak M; Soliman E; Rao P; Weir M; Bansal N;
Kidney Int Rep; 2020 Nov; 5(11):2002-2012. PubMed ID: 33163721
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study.
Lamprea-Montealegre JA; Zelnick LR; Shlipak MG; Floyd JS; Anderson AH; He J; Christenson R; Seliger SL; Soliman EZ; Deo R; Ky B; Feldman HI; Kusek JW; deFilippi CR; Wolf MS; Shafi T; Go AS; Bansal N;
J Am Heart Assoc; 2019 Aug; 8(15):e012200. PubMed ID: 31379242
[TBL] [Abstract][Full Text] [Related]
13. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
14. Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High-Sensitivity Troponin T, and N-Terminal Pro-Brain-Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction.
Lidgard B; Zelnick LR; Go A; O'Brien KD; Bansal N;
J Am Heart Assoc; 2022 Jun; 11(11):e024913. PubMed ID: 35621223
[TBL] [Abstract][Full Text] [Related]
15. Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
Oyama K; Giugliano RP; Berg DD; Ruff CT; Jarolim P; Tang M; Murphy SA; Lanz HJ; Grosso MA; Antman EM; Braunwald E; Morrow DA
Eur Heart J; 2021 May; 42(17):1698-1706. PubMed ID: 33760027
[TBL] [Abstract][Full Text] [Related]
16. Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]).
Mishra RK; Li Y; Ricardo AC; Yang W; Keane M; Cuevas M; Christenson R; deFilippi C; Chen J; He J; Kallem RR; Raj DS; Schelling JR; Wright J; Go AS; Shlipak MG;
Am J Cardiol; 2013 Feb; 111(3):432-8. PubMed ID: 23178053
[TBL] [Abstract][Full Text] [Related]
17. Cardiac biomarkers of heart failure in chronic kidney disease.
Han X; Zhang S; Chen Z; Adhikari BK; Zhang Y; Zhang J; Sun J; Wang Y
Clin Chim Acta; 2020 Nov; 510():298-310. PubMed ID: 32710942
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
[TBL] [Abstract][Full Text] [Related]
19. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers and diagnostics in heart failure.
Gaggin HK; Januzzi JL
Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
